Comparing the Efficacy and Safety of Different Postoperative Adjuvant Regimens in Patients With Resectable Adenocarcinoma of the Esophagogastric Junction Who Underwent Radical Surgery After Neoadjuvant Chemotherapy Combined With Immunotherapy and Achieved pCR in Postoperative Pathology
Clinical trial NCT07161453 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07161453
- Sponsor
- Liaoning Cancer Hospital & Institute
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-30
- Primary completion
- 2027-09-30
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.